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Background: Demand for shorter treatment time is common in orthodontic patients. Periodontally Accelerated 
Osteogenic Orthodontics (PAOO) is a somewhat new surgical procedure which allows faster tooth movement via 
combining orthodontic forces with corticotomy and grafting of alveolar bone plates. Leukocyte and Platelet-Rich 
Fibrin (L-PRF) possess hard- and soft-tissue healing properties. Further, evidence of pain-inhibitory and anti-
inflammatory potential is growing. Therefore, this study explores the feasibility, intra- and post-operative effects of 
using L-PRF in PAOO in terms of post-operative pain, inflammation, infection and post-orthodontic stability. 
Material and Methods: A pilot prospective observational study involving a cohort of 11 patients was carried out. 
A Wilcko’s modified PAOO technique with L-PRF (incorporated into the graft and as covering membrane) was 
performed with informed consent. Post-surgical pain, inflammation and infection were recorded for 10 days post-
operatively, while the overall orthodontic treatment and post-treatment stability were followed up to 2 years. 
Results: Accelerated wound healing with no signs of infection or adverse reactions was evident. Post-surgical 
pain was either “mild” (45.5%) or “moderate” (54.5%). Immediate post-surgical inflammation was either “mild” 
(89.9%) or “moderate” (9.1%). Resolution began on day 4 where most patients experienced either “mild” or no in-
flammation (72.7% and 9.1%, respectively). Complete resolution was achieved in all patients by day 8. The average 
orthodontic treatment time was 9.3 months. All cases were deemed stable for 2 years. 
doi:10.4317/jced.52760
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Introduction
Demand for shorter treatment time with none to mini-
mal side effects (i.e. root resorption, gingival recession, 
tooth decalcification, etc …) is a main request of adults 
seeking orthodontic treatment (1,2). Unlike children, 
adults have special biological conditions (i.e. slower cell 
mobili�ation and collagen conversion, increased risk of 
periodontal disease and almost inexistent alveolar and 
maxillary growth) which prevent speeding up treatment 
via conventional means (i.e. applying stronger forces) 
without increasing risk of hyalini�ation, among other 
complications (1). To overcome such limitations, di-
fferent techniques are constantly explored and develo-
ped over the years, to accelerate tooth movement, with 
surgical endeavors reporting the highest success rates. 
Indeed, such surgical attempts date back to 1959, when 
Kole theori�ed that cortical bone plates were the main 
resistance for tooth movement. Thereby, a corticotomy/
osteotomy procedure which selectively sectioned the 
plates, was presented with promising results. Despite, it 
was not widely accepted due to subapical hori�ontal cuts 
penetrating full thickness of the alveolar ridge (1). Sub-
sequent technical modifications included conservative 
corticotomies alongside the discovery that periodontal 
health could be maintained if the vertical cuts avoided 
the crestal bone area (1). This led the Wilcko brothers (a 
periodontist and an orthodontist) to introduce, in 2001 
a new technique for surgically-assisted tooth movement 
in orthodontics (3-6). Their technique combined clas-
sic corticotomies/osteotomies of the alveolar bone with 
the use of bone grafts in order to maintain and increa-
se the thickness of the cortical plates into which teeth 
were moved. Wilcko’s novel “Periodontally Accelerated 
Osteogenic Orthodontic or PAOO” technique gained 
acceptance and popularity given its safe, predictable 
and effective results as well as benefits versus traditio-
nal orthodontics; which included: accelerated differen-
tial tooth movement, reduced treatment time, less root 
resorption, enhanced expansion, increased traction of 
impacted teeth, increased post-treatment stability and 
increased robustness of the periodontum (including re-
cently reported increase in the width of keratini�ed gin-
giva) (1,4,7). With grafting, no more limits regarding 
pre-existing alveolar volume existed, allowing the teeth 
to be moved 2 to 3 times more (distance) and in almost 
Conclusions: L-PRF is simple and safe to use in PAOO. Combination with traditional bone grafts potentially accele-
rates wound healing and reduces post-surgical pain, inflammation, infection without interfering with tooth movement 
and/or post-orthodontic stability, over a 2 years period; thus alleviating the need for analgesics and anti-inflammatory 
medications.
Key words: Periodontally accelerated osteogenic orthodontics, leukocyte and platelet-rich fibrin, corticotomy, os-
teogenesis, grafts.
1/3rd of the conventional/traditional time (1,2,7). Today, 
main indications for PAOO include moderate to severe 
crowding, Class II malocclusions requiring expansion 
and/or extractions, mild Class III malocclusions, ex-
trusion for open bite and intrusion for deep bite (1,7). 
Recently, PAOO has also been suggested to reduce the 
need and extension of orthognathic surgery in specific 
patients, opening new and exciting frontiers and possibi-
lities within maxillofacial surgery (1,4,8). The rapid too-
th movement and stability, as a result of PAOO, has been 
attributed to a locali�ed and temporal osteoporosis-like/
increased turnover state of the bone, referred to as Regio-
nal Acceleratory Phenomenon or RAP (1). Briefly, RAP 
is a natural event within the bone healing process which 
usually follows fracture, osteotomy and/or grafting. The 
PAOO procedure, therefore, involves the activation and 
recruitment of precursor cells into the wounded/injured 
site, leading to subsequent two to ten-fold increase in 
hard and soft tissue healing (9). In PAOO, RAP begins 
within few days of the surgical intervention, peaks at 1 
to 2 months post-surgery and usually lasts up to 4 mon-
ths (though 6 and up to 24 months may be necessary to 
completely subside). However, as long as tooth move-
ment continues, RAP follows (1). As any healing-related 
event, RAP requires a delicate combination of progeni-
tor cells, extracellular signaling molecules and adequate 
extracellular matrix in order to succeed. In this “tissue 
engineering” context, biomaterials that support and en-
hance the regenerative process may further improve the 
clinical outcomes of PAOO while reducing side-effects 
(which often include: slight interdental bone loss, loss 
of attached gingiva, periodontal defects, subcutaneous 
hematomas and postoperative pain and swelling for se-
veral days) (1). Leukocyte and Platelet-Rich Fibrin or 
L-PRF is a second generation platelet hydrogel obtained 
through the simple and rapid centrifugation of whole 
blood samples in absence of anti-coagulants and bovine 
thrombin (10,11). The biomaterial is characteri�ed by a 
dense fibrin mesh (similar to natural extracellular ma-
trix) and rich platelet-, leukocyte-, growth factor- and 
stem cell-content (exceeding that of conventional blood 
clots and Platelet-Rich Plasma or PRP) (12). Accumu-
lating evidence (13,14) demonstrates that L-PRF mem-
branes actively produce and release abundant concentra-
tions of growth factors and cytokines for up to 28 days 
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post-preparation; exerting: (a) dose-dependent osteoin-
ductive effects over osteoblasts, periodontal ligament 
cells and bone marrow mesenchymal stem cells (which 
may be further increased via combination with autolo-
gous bone) as well as potential (b) anti-inflammatory, 
(c) anti-infective and (d) pain inhibitory properties (15); 
all of which are attractive properties suitable for incor-
poration into PAOO. Here in, we aimed to explore the 
clinical feasibility or effect of preparing and using L-
PRF in PAOO in terms of post-operative inflammation, 
pain, infection and short-term orthodontic stability, as 
the study outcomes.
Material and Methods 
-Study design and population
A cohort observational study was designed involving 
11 patients who visited our clinics between �une 2013 
and �une 2015. Inclusion criteria: (a) patients in need of 
orthodontic treatment whom desired a shorter treatment 
time and (b) patients whom (according to the Orthodontic 
and Periodontal specialists and consultants) were suita-
ble candidates for PAOO. �xclusion criteria: (a) patients 
with systemic health illnesses incompatible with under-
going surgery and (b) patients with active periodontal 
disease. Suitability for PAOO was confirmed after an ex-
tensive series of examinations which included: mounted 
model casts, radiographic analysis (panoramic and la-
teral radiographs), cephalometric analysis (�icker Sas-
souni) and both, intra and extra-oral photographs. This 
study complies with the guidelines of the World Medical 
Association-Helsinki Declaration 2000 for biomedical 
research and was reviewed, approved and supervised by 
the �thics committee (Medicine/Dentistry Schools) of 
the University of the Andes in Santiago, Chile.       
-L-PRF preparation.
Peripheral blood samples were drawn into 10 mL glass-
coated tubes without anti-coagulants (6-8 tubes per pa-
tient). Samples were immediately table-top centrifuged 
at 3000 rpm for 10 mins, according to the protocol de-
veloped by Choukroun et al. in 2001 (11). Clots were 
then carefully separated from red blood cell precipitants 
using scissors. Half of the clots were minced and incor-
porated into the bone graft while the other half prepared 
as a membrane using L-PRF box.         
-Surgical procedure
All surgeries (N=11) were performed by the same team. 
Following an informed and written consent, a modified 
“Wilcko” technique incorporating the use of L-PRF (60 
to 80 mL of blood per patient) as grafting material and 
barrier membrane, with antibiotic treatment. After ad-
ministration of anesthesia, full-thickness envelope flap 
is carefully raised preserving the interdental papillae. 
�ertical corticotomy patterns are performed using either 
rotary (�SCAROM n°2 round burs at 500 rpm) or pie�o-
electric (�SCAROM, BS1 tip) instruments. Cuts extend 
from 2 mm below the bone crest to approximately 2-3 
mm past the teeth apices, penetrating 1.5 to 2 mm into 
the cortical plate until reaching the cancellous bone [evi-
dence suggest that corticotomy pattern, depth, extent and 
means of creation (either rotary or pie�oelectric) are not 
crucial factors for the success of PAOO (4)]. After con-
trolling the bleeding, minced pieces of L-PRF (4 clots) 
are grafted with a 3:2 combination of Puros cortico-can-
cellous® (Zimmer Dental Inc, CA, USA) and Bio-Oss® 
(Geistlich Pharma North America Inc, Princeton, USA), 
respectively; with the addition of two (250 mg each) 
Metronida�ole capsules (total of 500 mg mixed into the 
graft). It is noteworthy that final graft volume varies ac-
cording to individual patient needs in terms of tooth mo-
vement, bone thickness and labial support. L-PRF mem-
branes (3 to 4 per patient) are then placed over the graft 
in order to contain it on the buccal aspect of the alveolar 
plate. Finally, the flap is repositioned and sutured using 
tension-free trans-papillary Donati Blair stitches (4-0 
vicyrl). The recommended post-operative management 
regimen typically includes: Chlorhexidine mouthwash 
(0.12%, every 6 hrs for 10 days), Amoxicillin (2 g every 
24 hrs for 7 days), Cortisol (30 mg every 24 hrs for 2 
days) and Ibuprofen (400 mg every 8 hrs, as needed). 
Sutures are removed ~ 10 days post-operatively. 
-Data collection
All 11 patients were monitored at days 1, 2, 4, 8 and 10 
post-op. At each time-point, complete clinical evalua-
tions with intra- and extra-oral photographs were perfor-
med. Post-surgical inflammation, infection and pain were 
recorded using clinical parameters and patient feedback. 
Briefly, inflammation was measured by means of pre-
sence and extension of clinical edema using a customi-
�ed scale. Infection was measured as either “present” (+) 
or “absent” (-) upon presence of abscesses, suppuration 
and/or fistulae. Finally, quantification and measurement 
of pain was made by patients via a customi�ed scale to 
report extent and need for post-operative analgesics. 
-Orthodontic procedure
All patients (N=11) were treated by the same orthodon-
tist. Full maxillary and mandibular braces with self-liga-
ting brackets were placed 7 days pre-surgery, followed 
by a 0.12, 0.14 or 0.16 NiTi arch protocol, according 
to the individual need of each patient; with activation 
every two weeks. Total treatment time (from placement 
of appliances until removal) and post-treatment stability 
were documented using rigid night guard splints. Stabi-
lity was recorded as either “stable” (if the splint fitted 
correctly) or “unstable” (if it did not fit). No post-or-
thodontic contentions were utili�ed.
-Statistical analysis
Descriptive statistics for baseline patient characteristics 
(age, gender, diagnosis, response to treatment and post-
orthodontic stability) were applied. Further testing was 
deemed un-necessary. 
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Results
�leven patients were enrolled in this study (3 males and 
8 women; average age: 34.8 years). All subjects com-
pleted the 2-years follow-up. Baseline demographic 
data and diagnosis are summari�ed in table 1. L-PRF 
preparation was done intra-operatively (~15 minutes) 
while performing corticotomy patterns; (Fig. 1). From 
clinician’s stand-point, the biomaterial was simple to 
prepare, handle and suture. In this technique, minced 
pieces of L-PRF mixed into the graft provide increased 
stability when placed on the buccal aspect of the surgical 
sites. Further, the L-PRF covering membranes supplied 
additional stability as well as graft protection against ex-
posure and contamination. After treatment with L-PRF, 
all patients experienced accelerated flap healing with 
no signs of infection or adverse reactions. Postoperati-
ve pain (based on post-surgical need of NSAIDs) was 
rated either as “mild” (45.5% of patients, analgesic con-
sumption up to 48 hrs post-op) or “moderate” (54.5% of 
patients, analgesic consumption up to 6 days post-op). 
No “severe” pain was reported (need of analgesic con-
sumption for more than 6 days) at any point of the study; 
Table 2. All patients showed clinical signs of edema on 
the first day. Inflammation (according to our customi�ed 
scale on clinical intra- and extra-oral edema) was either 
“mild” (89.9%, edema limited to the buccal aspect of the 
surgical site) or “moderate” (9.1%, edema on buccal as-
pect of the surgical site which also extended to neighbor 
intra-oral structures). Inflammatory peak was reached by 
day 2 with inflammation either increasing to “modera-
te” levels (72.7% of patients) or maintaining its origi-
nal extent (“moderate” in 9.1% of patients and “mild” 
in 18.2%). �dema resolution begun by day 4 with most 
patients (72.7%) exhibiting decreased inflammation le-
vels returning to a “mild” level of inflammation. Only 1 
patient (9.1%, Patient N° 11) experienced complete re-
solution (no clinical signs of intra- or extra-oral edema). 
Another subject (9.1%, Patient N° 8) presented no chan-
ges in his inflammatory levels from days 1 to 4, sustaining 
a “moderate” level inflammation. Overall, complete reso-
lution of the inflammatory process was achieved by day 
8 and continued on day 10. It is noteworthy that none of 
the patients presented “severe” inflammation (presence of 
intra- and extra-oral clinical signs of edema); Table 3.  Fi-
nally, the average time for orthodontic treatment was 9.3 
months (dispersion ranging from 3 to 18 months) and all 
cases maintained stability for at least 2 years post-surgery. 
It is worth mentioning that in this pro-cohort study, pa-
tients were generally satisfied and neither gender nor age 
seem to have any detrimental effect on the treatment time, 
result or post-treatment stability.
Discussion
PAOO is a new and un-explored territory in Dentistry. 
Most of accumulating evidence generates from obser-
vational and case-control studies. L-PRF is a 2nd ge-
neration platelet concentrate vastly used in oral and 
maxillofacial surgery due to its angiogenic, osteogenic 
and wound healing properties (15,16). To the best of our 
knowledge, a single report of L-PRF application within 
Patient P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 
Age 15 16 28 32 35 36 37 42 43 48 51 
Gender F M F F M F F F F F M 
Angle Class
(Canine)
1 3 1 2 1 2 2 2 2 3 1
Skeletal Class NB CL1 NB CL1 NB CL1 NB CL1 NB CL1 NB CL2 NB CL2 NB CL2 NB CL2 NB CL1 NB CL3 

Table 1. Demographic data and clinical diagnosis of patients (N=11) involved in the study.
Figure 1. L-PRF preparation.
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Consumption P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 
First 48 hours • • • • • • • • • • • 
3 to 6 days   • •  • • • •   
 6 days - - - - - - - - - - - 
Pain Intensity Mid Mid Moderate Moderate Mid Moderate Moderate Moderate Moderate Mid Mid 

Patient P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 
Day 1 + + + + + + + ++ + + + 
Day 2 ++ + ++ ++ ++ ++ ++ ++ ++ ++ + 
Day 4 + + + + + + + ++ + + - 
Day 8 - - - - - - - - - - - 
Day 10 - - - - - - - - - - - 

Table 2. Post-operative self-reported need for analgesics and overall pain intensity.
Table 3. Post-operative edema (after treatment with L-PRF).
PAOO (4) exists in the literature. The article uses L-PRF 
to increase bone graft stability over the surgical site (also 
evidenced in this study) without any further description 
of the method of application or evaluation of the resul-
ting intra- and post-operative clinical effects (4). Hence, 
the present cohort prospective study not only explored 
these questions but also proposes a methodological te-
chnique for L-PRF preparation and application suita-
ble for PAOO (a modified version of Wilcko’s PAOO) 
which includes the use of 4 L-PRF clots as grafting ma-
terial (minced and mixed into a 3:2 Puros®/Bio-Oss® 
graft) and 3 to 4 L-PRF membranes for coverage. An 
additional intra-operative medication of the graft with 
metronida�ole to protect the graft from the un-avoidable 
bacterial contamination during surgery, was done. Such 
methodological and technical decisions were deduced 
from another study (17) which evaluated the use of L-
PRF in complex maxillary reconstructions (resembling 
PAOO in duration and wound extensity). Here in, the 
wound healing and osteogenic properties of L-PRF were 
previously evaluated clinically by means of observing 
healing of the flap and post-orthodontic stability (which 
has been associated to post-treatment bone thickness (4) 
and thus proposed as an indirect non-invasive parameter 
for assessing the osteogenic potential of L-PRF). Our 
results regarding accelerated flap healing and long-term 
post-treatment stability (up to 2 years) not only support 
the wound healing and osteogenic properties of L-PRF, 
yet also suggest that the healing capacity of L-PRF may 
exceed the limits reported. Indeed, the surgical wound in 
PAOO greatly exceeds both in extension and complexity 
that of implant, periodontal and extraction-socket de-
fects (the main sources of human clinical trial evidence 
for L-PRF literature in Dentistry). The enhanced soft 
and hard tissue healing observed in this study may be 
attributed to the intrinsic properties of the L-PRF fibrin 
matrix, cellular- and growth factor-rich content, as well 
as the use of L-PRF as a covering membrane. It is a well-
established basic surgical principle that for healing, ade-
quate blood supply and protection of the surgical site are 
necessary. In addition, contemporary tissue engineering 
concepts propose the need of an adequate extracellular 
matrix, presence of progenitor cells and appropriate le-
vels of signaling molecules. �vidently, the corticotomies 
induced within PAOO assure a rich and vasculari�ed 
bed for the graft whereas L-PRF as cover membrane 
has been clinically associated with increased gingival 
remodeling and thickness (15,17). This combinatorial 
approach seems to reduce the risk of tear/dehiscence 
of the flap with subsequent graft exposure and conta-
mination, providing an optimal environment for wound 
healing. On the other hand, the sponge-like architectu-
re of the biomaterial provides an ideal scaffold for free 
cell migration into the surgical site; while the release of 
growth-factors for up to 28 days post-surgery, provides 
the continuous long-term stimuli required for chemo-
taxis and osteogenic differentiation of osteoblasts, pe-
riodontal ligament cells and bone-marrow mesenchymal 
stem cells (15). Furthermore, the presence of CD34+ 
stem cells within the L-PRF (18) provides availability 
of progenitor cells to augment the healing process. On 
the other hand, recently accumulated evidence inclu-
ding human trials using L-PRF in periodontal surgery 
associated L-PRF use with decreased post-surgical pain 
and inflammation (19,20). This concept is relatively new 
within the L-PRF literature and thus is still not fully un-
derstood. Plausible biological mechanisms behind this 
phenomenon (as well as for reduced post-surgical risk 
of infection) have been attributed to the leukocyte-rich 
content which produces: (1) anti-nociceptive molecules 
(such as b-endorphin, matenkephalin and dynorphin-a) 
and (2) anti-inflammatory cytokines (such as IL-4, IL-10 
and IL-13) (20). In this study, post-surgical pain (measu-
red by means of need for consuming non-steroidal anti-
inflammatory drugs or NSAIDs) and clinical inflamma-
tion (evaluated in terms of presence and extension of 
intra and extra-oral edema) was reduced with the use of 
L-PRF. Finally, despite the advantages of PAOO when 
compared to traditional orthodontics (1,4), patients are 
often discouraged due to fear of undergoing surgery with 
additional costs and post-operative discomfort (mainly 
pain, inflammation and risk of infection). In this context, 
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L-PRF may be a cost-effective way to increase patient 
acceptance and other major surgical interventions (i.e. 
distraction osteogenesis and orthognathic surgery, for 
example). An interesting topic for future investigation is 
to determine whether L-PRF reduces the need for post-
surgical NSAIDs. Avoiding such drugs not only could 
further improve tooth movement and post-orthodontic 
stability in PAOO (as NSAIDs have been associated 
with interference of bone metabolism and turnover), but 
also reduce the drug-related adverse effects in patients, 
thereby growing patient acceptance of maxillofacial or-
thognathic surgical procedures.
Conclusions
Findings of this study suggest that L-PRF is a simple, 
malleable and safe biomaterial suitable for use in PAOO. 
Combination with conventional particulate bone grafts 
seems to reduce post-operative inflammation, pain and 
risk of infection without interfering with tooth move-
ment or post-orthodontic stability (<2 years). This is cri-
tical since commonly-used analgesic and non-steroidal 
anti-inflammatory drugs are known to interfere with 
bone healing and tooth movement. Other drugs inclu-
ding aspirin, diclofenac, ibuprofen, indomethacin and 
celecoxib, reduce tooth movement via decreasing bone 
turnover due to orthodontic forces. Acetaminophen is 
the only analgesic drug with no documented negative 
effects bone physiology and metabolism. L-PRF might 
be a useful and effective alternative. Randomi�ed multi-
center prospective trials with more patients and longer 
follow-ups are currently undergoing. Cost-effectiveness 
and psycho-socio-economics are important aspects invol-
ved in the study design. To the best of knowledge, this 
is first report investigating the feasibility, clinical impact 
and short-term post-orthodontic stability of using L-PRF 
in PAOO. It introduces a modified PAOO technique. Our 
group is currently investigating the potential of incorpo-
rating oral-derived mesenchymal stem cells or growth-
factor embedded nanoparticles within the L-PRF, as 
bio-scaffolds, to further boost, with predictability, bone 
formation, tooth movement ability, treatment time and 
post-orthodontic stability, in PAOO. Our research extends 
to investigate the potential of L-PRF in reducing the need 
for prescription drugs following invasive surgical proce-
dures such as third molar extraction and cysts resections.
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